Journal description

The Journal of Medical Research and Innovation (JMRI) is an open-access peer-reviewed journal committed to publishing high-quality articles in the field of Medicine and its subspecialties with a special interest towards Hypothetical and Innovative Medical Science. JMRI publishes continuously throughout the year. Additional issues may be published for special events (e.g. conferences) and when special themes are addressed. 

ISSN: 2456-8139, Editor in Chief: Dr. Varshil Mehta, Publisher: Medkrux (from May, 2023)
Acceptance Rate (2022): 17.86%, Access: Open Access from 2020, Article Processing Charge: Know more
Index Copernicus Value-2020: 100, Impact Factor (Dimensions): 2.43, H-Index (Google Scholar): 14
Frequency: Continuous, Abbreviation: J Med Res Innov, Contact: editorialteam@jmrionline.com

We are accepting new manuscripts, please submit your manuscript by clicking the button below:



Letter to the Editor

Assessment of ‘Florence’ in Addressing Inquiries on Nicotine Replacement Therapy

by Billah M., Amin S., Barua O.

Summary: Dear editor,

Editorial

Artificial Intelligence in Medicine: Revolutionizing Healthcare for Improved Patient Outcomes

by Mehta V.

Summary: Artificial intelligence (AI) has emerged as a groundbreaking technology with the potential to transform various sectors, and the field of medicine is no exception. With its ability to process vast amounts of data and perform complex tasks, AI has begun to revolutionize healthcare, offering promising avenues for diagnosis, treatment, and patient care. In this editorial article, we will explore the significant impact of AI in medicine, highlighting its potential benefits and the challenges that lie ahead.

Case Series

Low back pain oswestry disability index changes following 8-week movement proficiency exercise program – A retrospective cohort study

by Williams B., Johnson D.

Summary: Chronic low back pain (CLBP) is a worldwide epidemic, with a prevalence rate of 75–84% in developed countries. With the prevalence increasing, health-care professionals must question current best practice guidelines. In 2014, spinal neurosurgeon and back pain rehabilitation specialist Dr. David Johnson developed a unique back pain rehabilitation program referred to as NearoHAB®. The program’s uniqueness is founded on the principle that effective rehabilitation must eliminate the root cause of pain symptoms. The NeuroHAB® 8-week Movement therapy program aims to reverse movement dysfunction by restoring central nervous system-derived motor patterns based on proficient spinopelvic biomechanics for bending activities of daily living. To date, no other rehabilitation methodology adopts a movement dysfunction cause-based clinical model for back pain symptoms or includes a framework for what healthy lumbar pelvic movement should resemble. Over the course of the 8-week program, each participant is gradually upskilled, developing new default movement proficiency and improved biomechanics, in efforts to downregulate pain, improve disability, and increase functional movement capacity, creating a positive feedback loop for further progress. The leading question of this study is “How does functional movement-based therapy impact chronic low back pain?” Ten sets of participant details were selected at random and retrieved from the NeuroHAB® 8-week program database of 2020. All participants presented with CLBP, and two oswestry disability index (ODI) scores were documented – the first at the beginning of the 8-week program, and the second after the NeuroHAB® intervention. ODI scores were collated and the pre- and post-program results were measured and compared quantitatively through a paired t-test to determine the statistical significance of improvement. Results showed a two-tailed P=0.05 indicating that there was a significant difference between the pre- and post-data (0.0024). The pre- and post-group intervention ODI means were 25.80 and 13.30, respectively, resulting in a difference of 12.50 (95% CI: 5.73–19.27); determining the mean data between the pre- and post-intervention decreased by 48.4496%. The results from this study support the alternative hypothesis, concluding an 8-week intervention of functional movement therapy represented by NeuroHAB® results in a significant reduction of LBP ODI scores

Editorial

Outcome of the first health skills simulation laboratory in the kingdom of Saudi Arabia

by Fatani M., Khan A., Albokhari​ A.

Summary: Simulation advanced medical education and medical personnel evaluation across the world.[1] For improving the healthcare skills of medical staff and clinical performance of health-care practitioners, the Ministry of Health issued a budget of three million Saudi Riyals to establish the first clinical skills and simulation center in the Kingdom of Saudi Arabia, in Makkah, at the beginning of 2003. The objectives were to establish a state-of-the-art simulation laboratory to improve the clinical performance of health-care practitioners, facilitate consistent formal clinical training, overcome the difficulties encountered by practitioners in actual practice in either the pre- or post-graduate period, and provide jobs through specialized training and education.

Case Report

The kaleidoscope of autoimmunity: A report of 10 cases of multiple autoimmune syndrome

by Gupta​ S., Aggarwal S., Chopra D.

Summary: Dear Sir,

Original Article

A novel approach of harvesting concentrated plasma-rich fibrin (PRF) with increased platelet count

by Ragunanthan N Devi​ C A., Hemavani V

Summary: The study concludes that protocol 1 was more efficient in harvesting platelets with less concentration of leukocytes, which is considered more suitable for various medical applications.

JMRI will start accepting submissions from February 2024

JMRI editorial board had taken a short time off from editorial process in order to focus on clinical field thus declining all submissions. However, from February 2024, we will restart accepting and processing submissions. 


Call for editorial board members

The Journal of Medical Research and Innovation is looking for its new editorial board members following the retirement of its current team in next few months.


JMRI Membership

Become a JMRI Member today and submit as many cases as you like and publish it for free within one year.


Call for papers (JMRI)

Any article submitted during May 2023, shall be published for free if accepted.

 


Update on publication

JMRI will again be published by Medkrux from May 1st, 2023 onwards on its orginal site www.jmrionline.com.


Index Copernicus Value

Index Copernicus Value for 2018 has been increased to 99.05 from 77.03 (2017 value).

 


More Updates




Updates

JMRI will start accepting submissions from February 2024

JMRI editorial board had taken a short time off from editorial process in order to focus on clinical field thus declining all submissions. However, from February 2024, we will restart accepting and processing submissions. 


Call for editorial board members

The Journal of Medical Research and Innovation is looking for its new editorial board members following the retirement of its current team in next few months.


JMRI Membership

Become a JMRI Member today and submit as many cases as you like and publish it for free within one year.


Call for papers (JMRI)

Any article submitted during May 2023, shall be published for free if accepted.

 


Update on publication

JMRI will again be published by Medkrux from May 1st, 2023 onwards on its orginal site www.jmrionline.com.


Index Copernicus Value

Index Copernicus Value for 2018 has been increased to 99.05 from 77.03 (2017 value).